| USD millions | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|
| Revenue | 36.9 | 48.1 | 91.2 | 116.2 | 142.1 | +22.3% | |
| Cost of revenue | 19.2 | 25.4 | 49.3 | 64.9 | 81.9 | +26.2% | |
| Gross profit | 17.7 | 22.8 | 41.9 | 51.3 | 60.3 | +17.3% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 10.6 | 10.9 | 17.3 | 23.6 | 38.2 | +62.0% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 10.6 | 10.9 | 17.3 | 23.6 | 38.2 | +62.0% | |
| Operating income | 7.1 | 11.8 | 24.6 | 27.8 | 22.1 | −20.6% | |
| Interest expense | 0.2 | 0.7 | 2.2 | 2.4 | 2.3 | −6.4% | |
| Interest income | 0.0 | 0.1 | 0.5 | 1.0 | 2.0 | +101.6% | |
| Other income / expense | 10.4 | 6.8 | 8.1 | 15.4 | 23.1 | +50.4% | |
| Pre-tax income | 17.5 | 18.7 | 32.7 | 43.1 | 45.1 | +4.7% | |
| Income tax | 0.0 | 0.1 | 14.3 | 3.7 | 2.8 | −23.8% | |
| Net income | 17.5 | 17.2 | 11.9 | 31.9 | 34.7 | +8.7% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | 0.17 | 0.17 | 0.12 | 0.31 | 0.34 | +9.7% | |
| EPS, diluted (per share) | 0.17 | 0.17 | 0.12 | 0.31 | 0.34 | +9.7% | |
| EBITDA | 10.5 | 18.6 | 39.7 | 49.6 | 61.8 | +24.8% | |
| Depreciation & amortization | 3.1 | 5.6 | 9.6 | 11.9 | 14.4 | +20.9% | |
| Weighted average shares (shares) | 102,401,332 | 102,401,332 | 102,401,332 | 102,401,332 | 102,401,332 | +0.0% | |
| Weighted average diluted shares (shares) | 102,401,332 | 102,401,332 | 102,401,332 | 102,401,332 | 102,401,332 | +0.0% | |
| Gross margin | 48.0% | 47.3% | 45.9% | 44.2% | 42.4% | −1.8 pts | |
| Operating margin | 19.1% | 24.6% | 27.0% | 23.9% | 15.5% | −8.4 pts | |
| Net margin | 47.4% | 35.8% | 13.0% | 27.5% | 24.4% | −3.0 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
Statements are reported in USD; the shares trade in SAR.